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1. Introduction 
α-Amino acids are essential to life as building blocks of 
peptides, proteins, hormones, and as a source of low-molecular 
weight nitrogenated substances with enormous biological 
importance such as glutathione, taurine, nitric oxide, polyamines, 
etc. The applicability of amino acids is also well documented as 
agrochemicals, antibacterial agents, fungicides, neuroactive 
compounds, food supplements, enzyme inhibitors and 
pharmaceutical materials.
1
 They are involved in the synthesis of a 
great number of organic substances as a source of chiral raw 
materials, as synthetic targets, and as reagents and/or catalysts in 
asymmetric synthesis.
2
 For all these reasons, the development of 
synthetic strategies for the preparation of amino acids has been 
object of intense investigation.
1
 Particularly, optically active 
phenylalanine analogs are interesting compounds because of their 
synthetic possibilities as chiral building blocks of more complex 
structures with relevance in the area of medicinal chemistry, as 
for instance, enzyme inhibitors.
3
 
In the last years, many efforts have been focused on the 
introduction of unnatural amino acids in peptidic chains to afford 
peptidomimetics designed to improve their binding potency to a 
desired biological target, their chemical and/or biological 
stability, and their pharmacokinetic properties compared to the 
natural compounds, providing useful information for the 
elucidation of different enzymatic mechanisms.
4
  
Biocatalytic and chemoenzymatic methods have been 
described for the production of unnatural or non-proteinogenic 
amino acids through many routes,
5
 receiving hydrolase-catalyzed 
reactions great attention due to their easy manipulation and 
commercial availability.
6
 Particularly, lipases (EC 3.1.1.3) have 
largely demonstrated their applicability with synthetic purposes, 
being the most employed enzymes in industrial processes in the 
last three decades. This fact is mainly based on their wide 
availability in nature and their broad substrate acceptance. 
Significantly this class of hydrolases acts with high levels of 
selectivity in the transformation of achiral but also racemic, 
prochiral or meso-compounds, their usefulness being extensively 
demonstrated through hydrolytic or synthetic processes in both 
aqueous and organic media.
7
 
Candida antarctica lipase B (CAL-B) is probably the most 
versatile catalyst,
8
 although others such as Pseudomonas cepacia 
lipase (PSL or PCL) or Rhizomucor miehei lipase (RML)
9
 have 
also shown excellent activities in a series of synthetic 
transformations such as aminolysis, esterification and 
transesterification reactions. Although less employed, the 
interconversion between two reacting esters (interesterification), 
is another process that can be successfully used operating with 
lipases.
10
 Herein, we wish to report our latest results in the field 
of asymmetric synthesis of amino acids. For that reason, a family 
of amino esters was chemically prepared to later explore their 
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kinetic resolution (KR), RML being found as the most versatile 
enzyme for interesterification reactions. 
 
2. Results and discussion 
Due to the relevance of phenylalanine analogs, a series of N-
acetylated O-esterified derivatives was synthesized through a 
four-step methodology. Starting from a common precursor, 
racemic ethyl acetamidocyanoacetate (1), firstly the alkylation at 
its α-position was carried out using the desired alkyl halide in 
order to afford the corresponding quaternary esters. These 
intermediates will be hydrolyzed, esterified and acetylated in the 
subsequent steps, giving access to the target compounds. With 
that purpose and considering that phase transfer catalysis is a 
highly demanded strategy for the synthesis of amino acids 
through alkylation reactions,
11
 this approach
 
was applied to the 
transformation of commercially available 1 with two equivalents 
of benzyl chloride (2), thus producing the N-acetyl amino ester 
(±)-3a in the presence of potassium carbonate at 70 ºC. A panel 
of phase transfer catalysts (PTCs) was employed such as 
benzyltriethylammonium bromide (BTAB), tetrabutylammonium 
hydrogen sulfate (TBAH), dodecyltrimethylammonium chloride 
(DTMAC), cetyltrimethylammonium bromide (CTMAB), 
benzyltributylammonium bromide (BTBAB) or 
benzyltributylammonium chloride (BTBAC), Aliquat or 18-
crown-6, obtaining in all cases moderate to good yields of (±)-3a 
as the unique product when 10 mol% of the PTC was used (Table 
1). The best results were achieved using the chloride salt 
BTBAC, so at this point benzyl bromide (4a) was used in order 
to improve the conversion of the process. Satisfyingly, the 
reaction with 4a led to a further improvement in the isolated 
yield of 3a in comparison with the reaction with 2 as alkylating 
agent (from 75 to 95% isolated yield, see entry 1 in Table 2). 
Table 1. Alkylation of (±)-1 with 2 (2 equivalents) and a 
phase transfer catalyst (10 mol%) in toluene and potassium 
carbonate (1 equivalent) for 5 h at 70 ºC. 
 
Entry PTC Isolated yield 3a (%)a 
1 BTAB 62 
2 TBAH 59 
3 DTMA 65 
4 CTMA 64 
5 BTBAB 63 
6 BTBAC 75 
7 Aliquat 66 
8 18-Crown-6 66 
a Isolated yield after flash chromatography. 
These conditions were then extended to other alkyl halides, 
selecting the bromide halides when they were commercially 
available. The results are summarized in Table 2, observing a 
slower reactivity for the 4-methoxybenzyl chloride (4b) in 
comparison with bromide salts 4a,c-h, all the amino esters being 
obtained with good to very high yields after 5 h. In addition, 
para-substituted derivatives with methyl (3c) or chloro 
substitution (3d) were achieved in 78-80% yield (entries 3 and 
4). Compounds bearing a nitro functionality led to excellent 
results independently of the substituent position (3e-g, entries 5-
7), while the most hindered naphtyl derivative 3h was isolated in 
89% yield (entry 8). 
Table 2. Alkylation of (±)-1 with 2 equivalents of alkyl 
halides (4a-h) and BTBAC (10 mol%) as PTC in toluene and 
potassium carbonate (1 equivalent) for 5 h at 70 ºC. 
 
Entry R1X Isolated yield 3a-h (%)a 
1 Benzyl bromide (4a) 95 
2 4-Methoxybenzyl chloride (4b) 52 
3 4-Methybenzyl bromide (4c) 78 
4 4-Chlorobenzyl bromide (4d) 80 
5 4-Nitrobenzyl bromide (4e) 93 
6 3-Nitrobenzyl bromide (4f) 94 
7 2-Nitrobenzyl bromide (4g) 92 
8 2-(Bromomethyl)naphthalene (4h) 89 
a Isolated yield after flash chromatography. 
The corresponding amino acid derivatives 3a-h were then 
subjected to a chemical sequence based on their acidic 
hydrolysis,
12
 subsequent esterification reaction using different 
alcohols (i.e. methanol, butanol or allyl alcohol), and final N-
acetylation protection (Scheme 1), leading to racemic compounds 
9a-h, 10a-h and 11a-h in a straightforward manner. In general 
moderate to good yields were obtained for the global three-step 
process, the poorer results being found with the allylic 
derivatives. 
Next, the enzymatic kinetic resolution of methyl N-acetylated 
amino ester 9a was studied. It must be mentioned that previous 
reports have appeared in the literature leading to the preparation 
of optically active N-acylated phenylalanine derivatives by means 
of highly selective hydrolytic processes,
13
 while 
transesterification reactions led to the desired compounds with 
high selectivity but modest conversions.
14
 For this reason, we 
decided to explore an alternative such as the interesterification 
reaction.
10
 Thus, butyl butyrate was selected as both resolving 
agent and solvent. A set of hydrolases including Candida 
antarctica lipase type A (CAL-A), Candida antarctica lipase 
type B (CAL-B), Candida rugosa lipase (CRL), porcine pancreas 
lipase (PPL), Pseudomonas cepacia lipase (PSL-IM), 
Rhizomucor miehei lipase (RML), lipase AK from Pseudomonas 
fluorescens (AK) and Thermomyces lanuginosus lipase (TLL) 
were tested in this reaction at 30 and 60 ºC. Only RML was able 
to produce the butyl ester in 53% conversion and 80% ee after 
8.2 h at 60 ºC (Table 3, entry 1), while no reaction was observed 
with the other lipases after 24 h. 
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Scheme 1. Chemical synthesis of racemic N-acetylated amino esters (±)-9-11. 
 
Then, the reaction was analyzed studying the influence of the 
temperature and the enzyme loading in the lipase catalysis. A 
slightly better enantiopreference was observed when the reaction 
was carried out in milder conditions (30 ºC, entry 2), attaining 
50% conversion after 48 h. In order to improve the reaction rate, 
enzyme loading was doubled leading to a similar conversion 
value at 24 h (entry 3). 
Table 3. Interesterification reaction of (±)-9a (120 mM) using 
butyl butyrate and RML. 
 
Entry Enzyme:9aa T (ºC) t (h) ees (%)
b eep (%)
b c (%)c Ed 
1 1:1 60 8.2 89 80 53 27 
2 1:1 30 48 86 85 50 34 
3 2:1 30 24 90 87 51 44 
a Ratio of RML:amino ester 9a in weight/weight. 
b Enantiomeric excess of substrate and product determined by HPLC. 
c Conversion value: c= ees/(ees+eep). 
d Enantioselectivity value: E= ln[1-c(1+eep)]/ln[1-c(1-eep)]. 
Looking at these results, we turned our attention to the solvent 
effect in the RML-catalyzed reaction. By this, tetrahydrofuran, 
1,4-dioxane, tert-butyl methyl ether, toluene, acetonitrile, n-
hexane and diethyl ether were tested using 5 equivalents of butyl 
butyrate (Table 4). The results were compared with the reaction 
carried out with PrCO2Bu as solvent (entry 1). Aliquots were 
regularly taken at intervals between 1 and 72 h, and the most 
representative results are shown. Reactions carried out at 30 ºC in 
THF, n-hexane and diethyl ether led almost to 50% conversion 
after 24 h with moderate enantioselectivity (E <50, entries 2-4), 
while in 1,4-dioxane the RML activity was lower with a similar 
selectivity (entry 5). 
Biotransformations in TBME and toluene (entries 6 and 7) 
showed the fastest reaction rates, attaining 47% conversion after 
only 8 h. Finally, an excellent selectivity was observed when the 
reaction was performed in acetonitrile, unfortunately the 
conversion value was not synthetically useful. For that reason, 
interesterification was carried out with 10 equivalents of butyl 
butyrate, but no changes were observed in the conversion. At this 
point, we decided to explore new insights in these processes, 
combining the use of different organic solvents with a lower 
temperature (4 ºC), trying in this way to obtain better 
stereoselectivities (entries 9-12). This goal was reached, and a 
remarkable conversion value of 48% was attained with MTBE 
(entry 11), while a better selectivity was observed for toluene 
(entry 12), although it decreased at longer reaction times. 
Table 4. Interesterification reaction of (±)-9a using butyl 
butyrate in different organic solvents.
a 
Entry Solvent T (ºC) t (h) ees (%)
b eep (%)
b c (%)c Ed 
1 PrCO2Bu 30 24 90 87 51 44 
2 THF 30 24 17 95 50 50 
3 n-Hexane 30 24 75 83 47 25 
4 Et2O 30 24 83 88 49 39 
5 Dioxane 30 72 44 94 32 50 
6 MTBE 30 8 79 88 47 38 
7 Toluene 30 8 79 93 47 38 
8 MeCN 30 24 16 >99 14 >200 
9 n-Hexane 4 24 41 89 32 35 
10 Et2O 4 24 31 96 24 63 
11 MTBE 4 24 83 92 48 64 
12 Toluene 4 24 96 49 34 89 
a Reaction conditions: 5 equivalents of butyl butyrate and RML (ratio 2:1 of 
enzyme:9a), 120 mM substrate concentration at 250 rpm. 
b Enantiomeric excess of substrate and product determined by HPLC. 
c Conversion value: c= ees/(ees+eep). 
d Enantioselectivity value: E= ln[1-c(1+eep)]/ln[1-c(1-eep)]. 
Once that the potential of the interesterification reaction was 
demonstrated in the resolution of the N-acetylated phenylalanine 
methyl ester, we decided to study the effect of the ester moiety 
making use of the allyl ester 11a as starting material. Due to the 
fact that the best selectivity achieved for 9a and PrCO2Bu was 
achieved employing MeCN as organic solvent, we decided to 
compare the effect of the substrate under these conditions (entries 
1 and 2, Table 5). As can be observed, a very high 
stereoselectivity towards the formation of the butyl ester (S)-10a 
and the allyl derivative (R)-11a was reached after 72 h of 
reaction. This trend was shared in all cases, the reactivity of the 
allyl amino esters (11) being much higher than the ones from the 
corresponding methylated derivatives (9). There was just one 
exception for the hindered ortho-nitrobenzyl compounds (9g and 
11g), which did not shown appreciable activity (entries 13 and 
14). Allyl para-substituted derivatives with methoxy (b), methyl 
(c), chloro (d) or nitro (e) functionalities produced the butyl 
esters in enantiopure form and gratifyingly with conversions 
close to 50% (47-48%, entries 4, 6, 8 and 10). For the 3-
nitrobenzyl ester (11f) and the 2-naphthylmethyl ester (11h) a 
significant lost of stereoselectivity was observed, but still better 
activities were achieved than for the methyl counterparts. 
3. Conclusions 
The selective synthesis on non-proteinogenic amino acid 
derivatives has been the focus of many efforts by organic 
chemists during the last years due to the novel properties attained 
when introduced in proteins and peptides. In this sense, while 
both enantiomers of phenylalanine could be obtained through 
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hydrolase-catalyzed resolutions through transesterification or 
hydrolysis processes,
13a,b,14
 the synthesis of other phenylalanine 
analogs has been scarcely studied.
13c,d
 Herein we show a 
methodology applicable for a series of phenylalanine derivatives 
making use of an interesterification reaction as a versatile 
approach to obtain them in an enantioenriched form. 
Twenty-four N-acetyl amino esters have been chemically 
prepared from easily accessible ethyl acetamidocyanoacetate (1) 
following a phase transfer catalytic C-alkylation, acidic 
hydrolysis and later esterification and acetylation sequence. 
Several phase transfer catalysts were tested in the reaction 
between 1 and alkyl halides, finding the best results with 
benzyltributylammonium chloride (BTBAC). The obtained 
methyl amino esters were then subjected to enzymatic kinetic 
resolution using a set of lipases as biocatalysts. Rhizomucor 
miehei lipase was found as a versatile enzyme for the asymmetric 
synthesis of the corresponding N-acetyl protected amino esters. 
The best results were found when carrying out interesterification 
reactions with butyl butyrate in acetonitrile as solvent at 30 ºC. A 
great influence in the activity and stereoselectivity has been 
observed depending on the chemical structure of the amino ester. 
Allyl esters reacted faster than the corresponding methyl esters, 
achieving, with the exception of the ortho-nitro amino ester, 
excellent stereoselectivities for the non- or para-substituted 
analogs in the phenyl ring, while moderate ones for the meta-
nitro or a bulky naphthalene derivative. 
Table 5. Interesterificaton reaction of (±)-9a-h and 11a-h 
(120 mM) using butyl butyrate and RML (ratio 2:1 in weight 
respect to the amino ester) in MeCN at 30 ºC and 250 rpm. 
 
Entry Substrate t (h) ees (%)
a eep (%)
a c (%)b Ec 
1 9a 24 16 >99 14 >200 
2 11a 72 90 98 48 >200 
3 9b 24 44 >99 31 >200 
4 11b 57 90 >99 48 >200 
5 9c 240 75 >99 43 >200 
6 11c 72 91 >99 48 >200 
7 9d 240 78 >99 44 >200 
8 11d 64 89 >99 47 >200 
9 9e 120 86 98 47 >200 
10 11e 30 90 >99 48 >200 
11 9f 144 48 84 37 18 
12 11f 72 81 87 48 35 
13 9g 240 <3 <3 <3 n.dd 
14 11g 24 <3 <3 <3 n.dd 
15 9h 120 27 92 23 31 
16 11h 120 81 78 49 19 
a Enantiomeric excess of substrate and product determined by HPLC. 
b Conversion value: c=ees/(ees+eep). 
c Enantioselectivity value: E= ln[1-c(1+eep)]/ln[1-c(1-eep)]. 
d n.d.: Not determined. 
 
4. Experimental section 
4.1. General considerations 
Chemical reagents were purchased from different commercial 
sources and used without further purification. Solvents were 
distilled over an adequate desiccant under nitrogen. Candida 
antarctica lipase type B (CAL-B, Novozyme 435, 7300 PLU/g) 
was a gift from Novozymes. Pseudomonas cepacia lipase 
currently known as Burkhlolderia cepacia lipase (PSL-IM, 1638 
U/g solid) and Pseudomonas fluorescens lipase (AK, 22100 U/g) 
were acquired from Sigma-Aldrich. Candida antarctica lipase A 
(CAL-A, 2.6 U/mg solid) was purchased from Codexis. Pancreas 
porcine lipase (PPL, 46 U/mg solid), Candida rugose lipase 
(CRL, 1.41 U/g) and Candida cylindracea lipase (CCL, 1.41 
U/mg solid) were obtained from Sigma. Rhizomuccor miehei 
lipase (RML, 150 IUN/g) and Thermomyces lanuginosus lipase 
(TLL, 250 IUN/g) were purchased from Novozymes. 
Flash chromatography was performed using silica gel 60 (230-
240 mesh). Melting points were taken on samples in open 
capillary tubes and are uncorrected. IR spectra were recorded on 
a Perkin-Elmer 1720-X F7 using NaCl plates or KBr pellets in. 
1
H, 
13
C NMR, and DEPT were obtained using AV-300 (
1
H, 
300.13 MHz and 
13
C, 75.5 MHz) and AV-400 (
1
H, 400.13 MHz 
and 
13
C, 100.6 MHz) spectrometers. The chemical shifts are 
given in delta () values and the coupling constants (J) in Hertz 
(Hz). High resolution mass spectra (HRMS) experiments were 
carried out by ESI
+
 using a BrukerMicroTofQ spectrometer. 
Measurement of the optical rotation was done in a Perkin-Elmer 
241 polarimeter. High performance liquid chromatography 
(HPLC) analyses were carried out in a Hewlett Packard 1100 
chromatograph with a UV detector at 210 nm using a Chiralpak 
AS column (25 cm  4.6 mm I.D.), Chiralpak IC (25 cm  4.0 
mm I.D.) and Chiralcel OB-H column (25 cm  4.6 mm I.D.). 
4.2. General procedure for the alkylation of racemic ethyl 
acetamidocyanoacetate (1) with alkyl halides 4a-h 
A suspension of (±)-1 (511 mg, 3 mmol), BTBAC (31 mg, 0.1 
mol), the corresponding alkyl halides (2 or 4a-h, 6 mmol), and 
potassium carbonate (415 mg, 3 mmol) were heated in toluene (5 
mL) for 5 h at 70 ºC under magnetic stirring. The reaction 
mixture was cooled to room temperature and diluted with CHCl3 
(20 mL), then the solution was washed with water (3 x 40 mL). 
The organic phase was dried with Na2SO4, filtered and the 
solvent evaporated under reduced pressure, obtaining a crude 
product that was purified by flash chromatography on silica gel 
(30-100% EtOAc/hexane). The amino esters 3a-h were obtained 
as solids in 52-95% isolated yield (see Table 2). 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-
phenylpropanoate (3a): Solid. Rf (50% EtOAc/hexane): 0.38. 
Mp: 121-122 °C. IR (NaCl): v 3277, 1753, 1668, 1527 and 1220 
cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 1.23 (t, 3H, J= 
14.3 Hz), 2.07 (s, 3H), 3.38 (d, 1H, J= 13.4 Hz), 3.52 (d, 1H, J= 
13.4 Hz), 4.16-4.30 (m, 2H), 6.87 (s, 1H), 7.23 (s, 1H) and 7.26-
7.37 (m, 5H). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 13.8 (CH3), 
22.6 (CH3), 41.6 (CH2), 57.9 (C), 63.7 (CH2), 116.4 (C), 128.6 
(CH), 128.9 (2CH), 130.1 (2CH), 131.7 (C), 165.8 (C) and 170.1 
(C). HRMS [ESI
+
, m/z] calcd for C14H16N2O3[Na
+
] 283.1059, 
found 283.1054. 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-(4-
methoxyphenyl)propanoate (3b): Solid. Rf (50% 
EtOAc/hexane): 0.16. Mp: 181-184 °C. IR (NaCl): v 3250, 1697, 
1633, 1512 and 1248 cm
-1
. 
1
H NMR (300.13 MHz, Py-d5) δ 
(ppm): 1.20 (t, 3H, J= 7.0 Hz), 2.23 (s, 3H), 3.76-3.89 (m, 5H), 
4.32-4.40 (m, 2H), 7.13 (dd, 2H, J= 11.4 and 3.0 Hz) and 7.62 
 5 
(dd, 2H, J= 11.2 and 2.4 Hz). 
13
C NMR (75.5 MHz, Py-d5) δ 
(ppm): 14.6 (CH3), 22.8 (CH3), 42.2 (CH2), 55.9 (C), 60.8 (CH3), 
63.7 (CH2), 115.1 (2CH), 119.0 (C), 125.5 (C), 132.7 (2CH), 
160.8 (C), 168.0 (C) and 171.6 (C). HRMS [ESI
+
, m/z] calcd for 
C15H18N2O4[Na
+
] 313.1164, found 313.1161. 
Spectroscopical data of ethyl 2-acetylamino-3-(4-
methylphenyl)-2-cyanopropanoate (3c): Solid. Rf (50% 
EtOAc/hexane): 0.3. Mp: 149.5-150.1 °C. IR (NaCl) v 3404, 
3250, 1730, 1697, 1512 and 1248 cm
-1
. 
1
H NMR (300.13 MHz, 
MeOD) δ (ppm): 1.10 (t, 3H, J= 6.0 Hz), 2.05 (s, 3H), 2.34 (s, 
3H), 4.06-4.12 (q, 2H, J= 6.0 Hz), 4.27-4.34 (m, 1H) and 7.18 (s, 
4H). 
13
C NMR (75 MHz, MeOH) δ (ppm): 14.1 (CH3), 21.2 
(CH3), 21.9 (CH3), 42.5 (CH2), 60.5 (CH2), 64.1 (C), 118.1 (C), 
130.2 (2CH), 130.3 (C), 131.3 (2CH), 139.4 (C), 167.6 (C) and 
173.2 (C). HRMS [ESI
+
, m/z] calcd for C15H18N2O3[Na
+
] 
297.1215, found 297.1209. 
Spectroscopical data of ethyl 2-acetylamino-3-(4-
chlorophenyl)-2-cyanopropanoate (3d): Solid. Rf (50% 
EtOAc/hexane): 0.28. Mp: 151-152 °C. IR (NaCl) v 3250, 1730, 
1697, 1512, 1248 and 1032 cm
-1
. 
1
H NMR (300.13 MHz, MeOD) 
δ (ppm): 1.13 (t, 3H, J= 7.1 Hz), 2.05 (s, 3H), 3.27 (d, 1H, J= 
13.4 Hz), 3.40 (d, 1H, J= 13.3 Hz), 4.09-4.15 (q, 2H, J= 7.1 Hz), 
7.30 (d, 2H, J= 8.7 Hz) and 7.38 (d, 2H, J= 8.7 Hz). 
13
C NMR 
(75.5 MHz, MeOD) δ (ppm): 14.1 (CH3), 21.8 (CH3), 41.9 (CH2), 
60.2 (C), 64.2 (CH2), 117.8 (C), 129.8 (2CH), 132.3 (C), 133.0 
(2CH), 135.5 (C), 167.4 (C) and 173.2 (C). HRMS [ESI
+
, m/z] 
calcd for C14H15N2O3Cl[Na
+
] 317.0669, found 317.0666. 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-(4-
nitrophenyl)propanoate (3e): Solid. Rf (60% EtOAc/hexane): 
0.31. Mp: 141-143 °C. IR (NaCl) v 3244, 3034, 1743, 1656, 1528 
and 1211 cm
-1
. 
1
H NMR (300.13 MHz, Py-d5) δ (ppm): 1.07 (t, 
3H, J= 7.2 Hz), 2.11 (s, 3H), 3.81 (d, 1H, J = 13.3 Hz), 3.92 (d, 
1H, J= 13.1 Hz), 4.24 (q, 2H, J= 7.2 Hz), 7.70 (d, 2H, J= 8.8 Hz) 
and 8.23 (d, 2H, J= 8.8 Hz). 
13
C NMR (75.5 MHz, Py-d5) δ 
(ppm): 14.3 (CH3), 22.6 (CH3), 41.7 (CH2), 59.9 (C), 63.9 (CH2), 
118.2 (C), 124.4 (2CH), 132.5 (2CH), 141.1 (C), 148.7 (C), 
167.3 (C) and 171.6 (C). HRMS [ESI
+
, m/z] calcd for 
C14H15N3O5[Na
+
] 328.0909, found 328.0909. 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-(3-
nitrophenyl)propanoate (3f): Solid. Rf (EtOAc/Hexane:MeOH 
4:5:1): 0.33. Mp: 120-123 °C. IR (NaCl) v 3244, 3043, 1759, 
1656, 1530 and 1204 cm
-1
. 
1
H NMR (300.13 MHz, Py-d5) δ 
(ppm): 1.04 (t, 3H, J= 7.2 Hz), 2.07 (s, 3H), 3.78-3.93 (m, 2H), 
4.18-4.25 (q, 2H, J= 7.2 Hz), 7.52 (apparent t, 1H, J= 7.9 Hz), 
7.90 (d, 1H, J= 7.6 Hz), 8.19 (dd, 1H, J= 8.3 and 1.5 Hz) and 
8.44 (s, 1H). 
13
C NMR (75 MHz, Py-d5) δ (ppm): 14.1 (CH3), 
22.3 (CH3), 41.3 (CH2), 59.9 (C), 63.7 (CH2), 117.9 (C), 125.9 
(CH), 130.3 (CH), 135.5 (CH), 137.4 (CH), 148.8 (C), 167.1 (C) 
and 171.4 (C). HRMS [ESI
+
, m/z] calcd for C14H15N3O5[Na
+
] 
328.0909, found 328.0915. 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-(2-
nitrophenyl)propanoate (3g): Solid. Rf (60% EtOAc/hexane): 
0.31. Mp: 140-143 °C. IR (NaCl) v 3241, 3045, 1755, 1659, 1529 
and 1202 cm
-1
. 
1
H NMR (300.13 MHz, Py-d5) δ (ppm): 1.05 (t, 
3H, J= 7.3 Hz), 2.07 (s, 3H), 4.18-4.23 (m, 3H), 4.42 (d, 1H, J= 
8.4 Hz), 7.44 (dd, 1H, J= 4.9 Hz, J= 0.9 Hz), 7.57 (apparent t, 
1H, J= 3.7 Hz), 7.74 (d, 1H, J= 4.6 Hz) and 8.07 (d, 1H, J= 4.8 
Hz). 
13
C NMR (75.5 MHz, Py-d5) δ (ppm): 14.6 (CH3), 23.0 
(CH3), 38.4 (CH2), 60.1 (C), 64.4 (CH2), 118.4 (C), 124.7 (CH), 
126.7 (CH), 128.9 (CH), 130.8 (CH), 134.4 (C), 135.2 (C), 167.6 
(C) and 171.8 (C). HRMS [ESI
+
, m/z] calcd for C14H15N3O5[Na
+
] 
328.0909, found 328.1001. 
Spectroscopical data of ethyl 2-acetylamino-2-cyano-3-
(naphthalen-2-yl)propanoate (3h): Solid. Rf (50% 
EtOAc/hexane): 0.21. Mp: 170-172 °C. IR (NaCl) v 3293, 1752, 
1666, 1528 and 1224 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ (ppm): 
1.25 (t, 3H, J= 7.3 Hz), 2.04 (s, 3H), 3.51 (d, 1H, J= 8.2 Hz), 
3.77 (d, 1H, J= 8.1 Hz), 4.22-4.33 (q, 2H, J= 7.3 Hz), 6.43 (s, 
1H) and 7.27-7.35 (m, 1H), 7.51 (m, 2H), 7.69 (s, 1H), 7.82 (m, 
3H). 
13
C NMR (125 MHz, CDCl3) δ (ppm): 13.9 (CH3), 22.7 
(CH3), 41.6 (CH2), 57.5 (C), 64.0 (CH2), 116.3 (C), 126.6-133.3 
(10 CAr), 165.9 (C) and 169.7 (C). HRMS [ESI
+
, m/z] calcd for 
C18H18N2O3[Na
+
] 333.1215, found 333.1214. 
4.3. General procedure for the hydrolysis of amino esters 3a-
h and subsequent esterification and N-acetylation reactions 
A suspension of amino ester 3a-h (0.3 M) in an aqueous 20% 
HCl solution (20 mL), was refluxed for 30 h, obtaining the amino 
acid salts 5a-h as white solids, which were washed with Et2O (30 
mL). Then a solution of 5a-h (0.03 M) in the corresponding 
alcohol (methanol, butanol or allyl alcohol, 30 mL) was prepared 
and a catalytic amount of a concentrated HCl solution (0.03 mL) 
was added. The solution was stirred at reflux for 1 h, and after 
that time the solvent was evaporated under reduced pressure, and 
the crude product was washed with Et2O (30 mL). The resulting 
solid without further purification was subjected to N-acetylation 
reaction, by dissolving it in CH2Cl2 (5 mL, 0.25 M), and then 
acetic anhydride (2.3 mL, 24.3 mmol), pyridine (1.0 mL, 12 
mmol) and DMAP (30.5 mg, 0.25 mmol) were added. The 
reaction was stirred at room temperature for 4 h, and then diluted 
with CH2Cl2 (30 mL) and washed with a 10% CuSO4 aqueous 
solution (3 x 30 mL). The reaction mixture was concentrated 
under reduced pressure and the reaction crude products were 
purified by flash chromatography on silica gel. The 
corresponding esters were obtained as follows: 9a-h (52-80% 
isolated yield), 10a-h (52-88% isolated yield) and 11a-h (43-
63% isolated yield), see Scheme 1 and Supporting Information 
for further details. 
4.4. General procedure for the lipase-catalyzed 
interesterification of 11a-h 
To a suspension of the corresponding allylated amino ester 
11a-h (20 mg, 0.09 mmol) and RML (40 mg) in dry MeCN (0.75 
mL), butyl butyrate (75 L, 0.45 mmol) was added under 
nitrogen atmosphere. The resulting suspension was shaken at 30 
ºC and 250 rpm in an orbital shaker, following the time course of 
the reactions by HPLC analysis (see further details in the 
Supporting Information). After the adequate time, the reaction 
was stopped, and the enzyme filtered off and washed with 
CH2Cl2 (15 mL). The solvent was evaporated under reduced 
pressure and the reaction crude purified by flash chromatography 
on silica gel (10-70% EtOAc/hexane), yielding (S)-11a-h and 
(R)-10a-h, and their enantiomeric excess (see Table 5) were 
determined by HPLC. 
Spectroscopical data of methyl 2-acetylamino-3-
phenylpropanoate (9a): Solid. Rf (50% EtOAc/hexane): 0.15. 
Mp: 88-90 ºC. IR (NaCl): v 3280, 1744, 1656, 1544 and 1217 cm
-
1
. 
1
H NMR (500 MHz, CDCl3) δ (ppm): 1.93 (s, 3H), 3.03 (dd, 
1H, J= 5.9 and 5.8 Hz), 3.10 (dd, 1H, J= 5.9 and 5.8 Hz), 3.68 (s, 
3H), 4.84 (ddd, 1H, J= 6.9, 6.8 and 6.0 Hz), 6.19 (br d, 1H, J= 
7.3 Hz), 7.07 (m, 2H) and 7.20-7.27 (m, 3H). 
13
C NMR (75.5 
MHz, CDCl3) δ (ppm): 23.1 (CH3), 37.9 (CH2), 52.4 (CH), 53.3 
(CH3), 127.2 (CH), 128.6 (2CH), 129.3 (2CH), 136.0 (C), 169.9 
(C) and 172.3 (C). HRMS [ESI
+
, m/z] calcd for C12H15NO3[Na
+
] 
244.095, found 244.0989. D
20
= -83.5 (c 1.0, CHCl3) for 82% 
ee of the (R)-enantiomer. Lit D
20
= -96.3 (c 1.0, CHCl3) for 
Tetrahedron 6 
90% ee of the (R)-enantiomer.
15
 Lit D
20
= -99.3 (c 1.0, 
CHCl3) for 94% ee of the (R)-enantiomer.
16
 
Spectroscopical data of butyl 2-acetylamino-3-
phenylpropanoate (10a): Oil. Rf (50% EtOAc/hexane): 0.38. IR 
(NaCl) v 3282, 2960, 1740, 1659, 1549 and 1211 cm
-1
. 
1
H NMR 
(500 MHz, CDCl3) δ (ppm): 0.90 (t, 3H, J= 14.8 Hz), 1.28-1.35 
(m, 2H), 1.54-1.60 (m, 2H), 1.97 (s, 3H), 3.06-3.14 (m, 2H), 
4.04-4.13 (m, 2H), 4.85 (m, 1H), 6.02 (br d, 1H, J= 7.0 Hz), 7.09 
(m, 2H) and 7.21-7.28 (m, 3H). 
13
C NMR (125 MHz, CDCl3) δ 
(ppm): 13.8 (CH3), 19.2 (CH2), 23.3 (CH3), 30.6 (CH2), 38.2 
(CH2), 53.4 (CH), 65.6 (CH2), 127.2 (CH), 128.7 (2CH), 129.5 
(2CH), 136.1 (C), 169.8 (C) and 172.0 (C). HRMS [ESI
+
, m/z] 
calcd for C15H21NO3[Na
+
] 286.1419, found 286.1383. D
20
= 
+7.5 (c 1.0, CHCl3) for 98% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-
phenylpropanoate (11a): Oil. Rf (50% EtOAc/hexane): 0.28. IR 
(NaCl) v 3283, 1743, 1659, 1539 and 1230 cm
-1
. 
1
H NMR (500 
MHz, CDCl3) δ (ppm): 2.01 (s, 3H), 3.16 (m, 2H), 4.63 (d, 2H, 
J= 6.0 Hz), 4.93 (d, 1H, J= 7.5 Hz), 5.31 (m, 2H), 5.88 (m, 1H), 
5.97 (br d, 1H, J= 6.5 Hz), 7.12 (m, 2H) and 7.27-7.32 (m, 3H). 
13
C NMR (125 MHz, CDCl3) δ (ppm): 23.3 (CH3), 38.0 (CH2), 
53.3 (CH), 66.3 (CH2), 119.3 (CH2), 127.3 (CH), 128.7 (2CH), 
129.5 (2CH), 131.5 (CH), 135.9 (C), 169.8 (C) and 171.5 (C). 
HRMS [ESI
+
, m/z] calcd for C14H17NO3[Na
+
] 270.1106, found 
270.1101. D
20
= -58.2 (c 1.0, CHCl3) for 90% ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(4-
methoxyphenyl)propanoate (9b): Solid. Rf (50% 
EtOAc/hexane): 0.16. Mp: 106-107 ºC. IR (NaCl): v 3280, 1748, 
1640, 1511 and 1223 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ 
(ppm): 2.00 (s, 3H), 3.01-3.14 (m, 2H), 3.74 (s, 3H), 3.80 (s, 3H), 
4.85 (dd, 1H, J= 7.2 and 5.7 Hz), 5.92 (br d, 1H, J= 7.2 Hz), 6.83 
(d, 2H, J= 8.6 Hz) and 7.02 (d, 2H, J= 8.6 Hz). 
13
C NMR (75.5 
MHz, CDCl3) δ (ppm): 23.0 (CH3), 37.1 (CH2), 52.2 (CH), 53.1 
(CH3), 55.2 (CH3), 114.1 (2CH), 127.8 (C), 130.2 (2CH), 158.7 
(C), 169.8 (C) and 172.0 (C). HRMS [ESI
+
, m/z] calcd for 
C13H17NO4[Na
+
] 274.1055, found 274.1052. D
20
= -45.2 (c 1.0, 
CHCl3) for 44% ee of the (R)-enantiomer. Lit D
20
= +82.3 (c 
1.0, CHCl3) for 84.5% ee of the (S)-enantiomer.
15
 Lit D
20
= 
+102.5 (c 1.0, CHCl3) for >99% ee of the (S)-enantiomer.
17 
Spectroscopical data butyl 2-acetylamino-3-(4-
methoxyphenyl)propanoate (10b): Oil. Rf (50% 
EtOAc/hexane): 0.23. IR (NaCl): v 3276, 1752, 1648, 1527 and 
1221 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 0.92 (t, 3H, 
J=7.3 Hz), 1.28-1.40 (m, 2H), 1.55-1.64 (m, 2H), 1.98 (s, 3H), 
2.99-3.17 (m, 2H), 3.78 (s, 3H), 3.99-4.12 (m, 2H), 6.0 (br d, 1H, 
J= 7.4 Hz), 6.82 (d, 2H, J= 8.4 Hz), 7.02 (d, 2H, J= 8.5 Hz). 
13
C 
NMR (75.5 MHz, CDCl3) δ (ppm): 13.8 (CH3), 19.2 (CH2), 23.3 
(CH3), 30.7 (CH2), 37.3 (CH2), 53.5 (CH), 55.4 (CH3), 65.5 
(CH2), 114.1 (2CH), 128.0 (C), 130.4 (2CH), 158.9 (C), 169.8 
(C) and 172.1 (C). HRMS [ESI
+
, m/z] calcd for C16H23NO4[Na
+
] 
316.1525, found 316.1523. D
20
= +53.7 (c 0.8, CHCl3) for 
>99% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-(4-
methoxyphenyl)propanoate (11b): Oil. Rf (50% 
EtOAc/hexane): 0.18. IR (NaCl): v 3280, 1759, 1642, 1521 and 
1232 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 1.98 (s, 3H), 
3.07 (dd, 2H, J= 6.8 and 3.5 Hz), 3.78 (s, 3H), 4.61 (d, 2H, J= 5.5 
Hz), 4.86 (d, 1H, J= 7.7 Hz), 5.25-5.34 (m, 2H), 5.88 (m, 1H), 
5.99 (s, 1H), 6.81 (d, 2H, J= 8.5 Hz) and 7.01 (d, 2H, J= 8.5 Hz). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 23.3 (CH3), 37.2 (CH2), 
53.5 (CH), 55.4 (CH3), 66.2 (CH2), 114.2 (2CH), 119.3 (CH2), 
127.9 (CH), 130.5 (2CH), 131.6 (2CH), 158.9 (C), 169.9 (C) and 
171.6 (C). HRMS [ESI
+
, m/z] calcd for C15H19NO4[Na
+
] 
300.1212, found 320.1210. D
20
= -39.1 (c 0.6, CHCl3) for 90% 
ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(4-
methylphenyl)propanoate (9c): Solid. Rf (50% EtOAc/hexane): 
0.28. Mp: 123-123.6 °C. IR (NaCl): v 3273, 1747, 1662, 1521 
and 1207 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 1.96 (s, 
3H), 2.30 (s, 3H), 2.99-3.13 (m, 2H), 3.71 (s, 3H), 4.81-4.88 (m, 
1H), 6.07 (br d, 1H, J= 7.4 Hz), 6.97 (d, 2H, J= 7.8 Hz) and 7.08 
(d, 2H, J= 7.7 Hz). 
13
C NMR (75 MHz, CDCl3) δ (ppm): 21.1 
(CH3), 23.1 (CH3), 37.4 (CH2), 52.3 (CH), 53.2 (CH3), 129.1 
(2CH), 129.3 (2CH), 132.7 (C), 136.7 (C), 169.7 (C) and 172.2 
(C). HRMS [ESI
+
, m/z] calcd for C13H17NO3[Na
+
] 258.1106, 
found 258.1059. D
20
= -43.8 (c 1.0, CH2Cl2) for 75% ee (R). 
Spectroscopical data of butyl 2-acetylamino-3-(4-
methylphenyl)propanoate (10c): Solid. Rf (50% 
EtOAc/hexane): 0.37. Mp: 62.7-63.0 ºC. IR (NaCl) v 3270, 1756, 
1642, 1559 and 1211 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ 
(ppm): 0.94 (t, 3H, J= 7.3 Hz), 1.27-1.42 (m, 2H), 1.56-1.66 (m, 
2H), 2.00 (s, 3H), 3.01-3.13 (m, 2H), 3.79 (s, 3H), 4.09-4.15 (m, 
2H), 4.81-4.87 (m, 1H), 5.92 (br d, 1H, J= 7.9 Hz), 6.83 (dd, 2H, 
J= 6.8 and 2.0 Hz) and 7.02 (dd, 2H, J= 6.7 and 2.0 Hz). 
13
C 
NMR (75 MHz, CDCl3) δ (ppm): 13.8 (CH3), 19.2 (CH2), 23.3 
(CH3), 30.7 (CH2), 37.3 (CH2), 53.5 (CH), 55.4 (CH3), 65.5 
(CH2), 114.1 (2CH), 128.0 (C), 130.5 (2CH), 158.9 (C), 169.7 
(C) and 172.0 (C). HRMS [ESI
+
, m/z] calcd for C16H23NO3[Na
+
] 
300.1576, found 300.1553. D
20
= +45.4 (c 1.0, CHCl3) for 
>99% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-(4-
methylphenyl)propanoate (11c): Oil. Rf (75% EtOAc/hexane): 
0.48. IR (NaCl) v 3259, 1749, 1640, 1211 and 891 cm
-1
. 
1
H NMR 
(300.13 MHz, CDCl3) δ (ppm): 1.99 (s, 3H), 2.31 (s, 3H), 3.09 
(m, 2H), 4.61 (d, 2H, J= 5.7 Hz), 4.88 (ddd, 1H, J= 7.5, 6.7 and 
5.8 Hz), 5.30 (m, 2H), 5.89 (m, 1H), 6.02 (br d, 1H, J= 7.5 Hz), 
6.99 (d, 2H, J= 7.9 Hz) and 7.09 (d, 2H, J= 7.9 Hz). 
13
C NMR 
(75 MHz, CDCl3) δ (ppm): 21.2 (CH3), 23.3 (CH3), 37.6 (CH2), 
53.4 (CH), 66.2 (CH2), 119.3 (CH2), 129.4 (2CH), 129.5 (2CH), 
131.6 (CH), 132.8 (C), 136.9 (C), 170.0 (C) and 171.7 (C). 
HRMS [ESI
+
, m/z] calcd for C15H19NO3[Na
+
] 284.1263, found 
284.1220. D
20
= -53.9 (c 0.7, CHCl3) for 91% ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(4-
chlorophenyl)propanoate (9d): Oil. Rf (50% EtOAc/hexane): 
0.49. IR (NaCl) v 3267, 1748, 1691, 1503, 1201 and 1049 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 1.99 (s, 3H), 3.09 (dd, 
1H, J= 14.0 and 5.8 Hz), 3.13 (dd, 1H, J= 14.0 and 6.0 Hz), 3.73 
(s, 3H), 4.87 (ddd, 1H, J= 7.4, 6.0 and 5.8 Hz), 6.05 (br d, 1H, J= 
7.4 Hz), 7.03 (d, 2H, J= 8.4 Hz) and 7.26 (d, 2H, J= 8.5 Hz). 
13
C 
NMR (75 MHz, CDCl3) δ (ppm): 23.3 (CH3), 37.5 (CH2), 52.6 
(CH3), 53.3 (CH), 128.9 (2CH), 130.8 (2CH), 133.3 (C), 134.6 
(C), 169.9 (C) and 172.1 (C). HRMS [ESI
+
, m/z] calcd for 
C12H14NO3Cl[Na
+
] 278.0560, found 278.0559. D
20
= -101.9 (c 
1.0, CHCl3) for 78% ee (R). 
Spectroscopical data of butyl 2-acetylamino-3-(4-
chlorophenyl)propanoate (10d): Oil. Rf (50% EtOAc/hexane): 
0.35. IR (NaCl) v 3259, 1750, 1683, 1512 and 1021 cm
-1
. 
1
H 
NMR (300.13 MHz, CDCl3) δ (ppm): 0.92 (t, 3H, J= 7.1 Hz), 
1.26-1.38 (m, 2H), 1.53-1.63 (m, 2H), 1.99 (s, 3H), 3.02-3.15 (m, 
2H), 4.03-4.17 (m, 2H), 4.82-4.88 (m, 1H), 6.13 (br d, 1H, J= 7.5 
Hz), 7.04 (d, 2H, J= 7.9 Hz) and 7.25 (d, 2H, J= 8.4 Hz). 
13
C 
NMR (75 MHz, CDCl3) δ (ppm): 13.8 (CH3), 19.2 (CH2), 23.3 
(CH3), 30.6 (CH2), 37.6 (CH2), 53.3 (CH), 65.8 (CH2), 128.9 
(2CH), 130.8 (2CH), 133.2 (C), 134.7 (C), 170.0 (C) and 171.9 
(C). HRMS [ESI
+
, m/z] calcd for C15H20NO3Cl[Na
+
] 320.1029, 
found 320.0994. D
20
= +77.6 (c 0.5, CHCl3) for >99% ee (S). 
 7 
Spectroscopical data of allyl 2-acetylamino-3-(4-
chlorophenyl)propanoate (11d): Solid. Rf (50% 
EtOAc/hexane): 0.42. Mp: 140-141.2 °C. IR (NaCl) v 1754, 
1699, 1523, 1225 and 1046 cm
-1
.
 1
H NMR (300.13 MHz, CDCl3) 
δ (ppm): 2.00 (s, 3H), 3.04-3.18 (m, 2H), 4.62 (d, 2H, J=5.9 Hz), 
4.89 (m, 1H), 5.26-5.36 (m, 2H), 5.81-5.89 (m, 1H), 6.26 (br d, 
1H, J= 7.6 Hz), 7.06 (d, 2H, J= 8.3 Hz) and 7.26 (d, 2H, J= 8.5 
Hz). 
13
C NMR (75 MHz, CDCl3) δ (ppm): 23.0 (CH3), 37.3 
(CH2), 53.2 (CH), 66.2 (CH2), 119.3 (CH2), 128.7 (2CH), 130.7 
(2CH), 131.3 (CH), 133.0 (C), 134.5 (C), 169.9 (C) and 171.2 
(C). HRMS [ESI
+
, m/z] calcd for C14H16NO3Cl[Na
+
] 304.0716, 
found 304.0710. D
20
= -24.9 (c 0.7, CHCl3) for 89% ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(4-
nitrophenyl)propanoate (9e): Solid. Rf (EtOAc): 0.45. Mp: 112-
113 °C. IR (NaCl): v 3278, 1743, 1654, 1352, 1219 and 736 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 2.02 (s, 3H), 3.19 (dd, 
1H, J= 13.9 and 5.7 Hz), 3.32 (dd, 1H, J= 13.7 and 6.1 Hz), 3.76 
(s, 3H), 4.94 (ddd, 1H, J= 7.4, 7.3 and 5.8 Hz), 6.03 (br d, 1H, J= 
6.8 Hz), 7.30 (d, 2H, J= 8.7 Hz) and 8.17 (d, 2H, J= 8.6 Hz). 
13
C 
NMR (75.5 MHz, CDCl3) δ (ppm): 25.1 (CH3), 39.9 (CH2), 54.6 
(CH3), 54.9 (CH), 125.7 (2CH), 132.2 (2CH), 145.8 (C), 149.2 
(C), 171.7 (C) and 173.5 (C). HRMS [ESI
+
, m/z] calcd for 
C12H14N2O5[Na
+
] 289.0800, found 289.0801. D
20
= -83.6 (c 0.7, 
CHCl3) for 86% ee (R). 
Spectroscopical data of butyl 2-acetylamino-3-(4-
nitrophenyl)propanoate (10e): Solid. Rf (EtOAc/Hexane/MeOH 
4:5:1): 0.5. Mp: 102.9-103.4 °C. IR (NaCl) v 3271, 3060, 1759, 
1670, 1536 and 1209 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ 
(ppm): 0.93 (t, 3H, J= 7.2 Hz), 1.27-1.39 (m, 2H), 1.55-1.65 (m, 
2H), 2.03 (s, 3H), 3.16-3.33 (m, 2H), 4.06-4.21 (m, 2H), 4.95 (m, 
1H), 6.07 (br d, 1H, J= 7.2 Hz), 7.31 (d, 2H, J= 8.7 Hz) and 8.17 
(d, 2H, J= 8.7 Hz). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 15.6 
(CH3), 21.0 (CH2), 25.1 (CH3), 32.5 (CH2), 40.0 (CH2), 54.9 
(CH), 67.8 (CH2), 125.6 (2CH), 132.2 (2CH), 145.9 (C), 149.2 
(C), 171.7 (C) and 173.2 (C). HRMS [ESI
+
, m/z] calcd for 
C15H20N2O5[Na
+
] 331.1270, found 331.1295. D
20
= +93.1 (c 
1.0, CHCl3) for 98% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-(4-
nitrophenyl)propanoate (11e): Solid. Rf (EtOAc/Hexane:MeOH 
4:5:1): 0.78. Mp: 92-94 °C. IR (NaCl): v 3280, 1761, 1650, 1529 
and 1355 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 2.01 (s, 
3H), 3.19 (dd, 1H, J= 13.7 and 5.7 Hz), 3.31 (dd, 1H, J= 13.8 and 
6.3 Hz), 4.62 (d, 2H, J= 5.8 Hz), 4.94 (m, 1H), 5.27-5.35 (m, 
2H), 5.80-5.93 (m, 1H), 6.04 (br d, 1H, J= 7.2 Hz), 7.30 (d, 2H, 
J= 8.5 Hz) and 8.14 (d, 2H, J= 8.5 Hz). 
13
C NMR (75.5 MHz, 
CDCl3) δ (ppm): 23.3 (CH3), 38.0 (CH2), 53.1 (CH), 66.6 (CH2), 
119.9 (CH2), 123.9 (2CH), 130.4 (2CH), 131.2 (2CH), 144.0 (C), 
147.4 (C), 169.9 (C) and 171.0 (C). HRMS [ESI
+
, m/z] calcd for 
C14H16N2O5[Na
+
] 315.0957, found 315.0955. D
20
= -37.0 (c 0.7, 
CHCl3) for 90% ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(3-
nitrophenyl)propanoate (9f): Oil. Rf (50% EtOAc/hexane): 
0.47. IR (NaCl): v 3280, 1744, 1658, 1530 and 1352 cm
-1
. 
1
H 
NMR (300.13 MHz, CDCl3) δ (ppm): 2.00 (s, 3H), 3.17 (dd, 1H, 
J= 13.7 and 5.8 Hz), 3.31 (dd, 1H, J= 13.9 and 5.7 Hz), 3.76 (s, 
3H), 4.92 (m, 1H), 6.23 (br d, 1H, J= 6.8 Hz), 7.48 (d, 2H, J= 5.2 
Hz), 7.98 (s, 1H) and 8.11 (m, 1H). 
13
C NMR (75.5 MHz, CDCl3) 
δ (ppm): 25.0 (CH3), 39.6 (CH2), 54.6 (CH3), 55.0 (CH), 124.2 
(CH), 126.2 (CH), 131.5 (CH), 137.4 (CH), 140.2 (C), 150.2 (C), 
171.9 (C) and 173.6 (C). HRMS [ESI
+
, m/z] calcd for 
C12H14N2O5[Na
+
] 289.0800, found 289.0803. D
20
= -90.6 (c 1.0, 
CH2Cl2) for 60% ee (R). 
Spectroscopical data of butyl 2-acetylamino-3-(3-
nitrophenyl)propanoate (10f): Solid. Rf (50% EtOAc/hexane): 
0.38. Mp: 103-105 °C. IR (NaCl) v 3280, 3071, 1740, 1659, 1531 
and 1211 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 0.88 (t, 
3H, J= 7.6 Hz), 1.23-1.35 (m, 2H), 1.52-1.61 (m, 2H), 1.96 (s, 
3H), 3.13 (dd, 1H, J= 13.9 and 6.1 Hz), 3.26 (dd, 1H, J= 13.7 and 
6.0 Hz), 4.09 (t, 2H, J= 6.6 Hz), 4.83-4.89 (m, 1H), 6.47 (br d, 
1H, J= 7.2 Hz), 7.41-7.49 (m, 2H), 7.97 (s, 1H) and 8.06 (d, 1H, 
J= 7.4 Hz). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 15.6 (CH3), 
21.0 (CH2), 24.9 (CH3), 32.4 (CH2), 39.6 (CH2), 55.1 (CH), 67.7 
(CH2), 124.1 (CH), 126.2 (CH), 131.4 (CH), 137.5 (CH), 140.4 
(C), 150.2 (C), 172.0 (C) and 173.3 (C). HRMS [ESI
+
, m/z] calcd 
for C15H20N2O5[Na
+
] 331.1270, found 331.1267. D
20
= +51.9 (c 
0.9, CHCl3) for 87% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-(3-
nitrophenyl)propanoate (11f): Oil. Rf (60% EtOAc/hexane): 
0.34. IR (NaCl): v 3277, 1743, 1659, 1531 and 1352 cm
-1
. 
1
H 
NMR (300.13 MHz, CDCl3) δ (ppm): 1.99 (s, 3H), 3.17 (dd, 1H, 
J= 13.9 and 6.0 Hz), 3.30 (dd, 1H, J= 13.9 and 5.9 Hz), 4.62 (m, 
2H), 4.92 (m, 1H), 5.25-5.34 (m, 2H), 5.87 (m, 1H), 6.33 (br d, 
1H, J= 7.4 Hz), 7.43-7.51 (m, 2H), 7.98 (d, 1H, J= 2.0 Hz) and 
8.08 (m, 1H). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 23.3 (CH3), 
37.9 (CH2), 53.4 (CH), 68.7 (CH2), 120.0 (CH2), 122.5 (CH), 
124.6 (CH), 129.7 (CH), 131.3 (CH), 135.9 (CH), 138.5 (C), 
148.5 (C), 170.2 (C) and 171.2 (C). HRMS [ESI
+
, m/z] calcd for 
C14H16N2O5[Na
+
] 315.0957, found 315.0954. D
20
= -67.9 (c 0.8, 
CHCl3) for 81% ee (R). 
Spectroscopical data of methyl 2-acetylamino-3-(2-
nitrophenyl)propanoate (9g): Oil. Rf (60% EtOAc/hexane): 
0.23. IR (NaCl): v 3278, 1740, 1659, 1541 and 1339 cm
-1
. 
1
H 
NMR (300.13 MHz, CDCl3) δ (ppm): 1.94 (s, 3H), 3.33 (dd, 1H, 
J= 13.9 and 8.0 Hz), 3.52 (dd, 1H, J= 13.9 and 6.0 Hz), 3.72 (s, 
3H), 4.92 (dt, 1H, J= 7.9 and 5.8 Hz), 6.32 (br d, 1H, J= 7.7 Hz), 
7.39-7.45 (m, 2H), 7.57 (dt, 1H, J= 7.8 and 1.4 Hz) and 7.92 (dd, 
1H, J= 7.9 and 1.4 Hz). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 
23.3 (CH3), 35.0 (CH2), 53.0 (CH), 53.3 (CH3), 125.3 (CH), 
128.6 (CH), 131.9 (C), 133.1 (CH), 133.5 (CH), 150.3 (C), 170.3 
(C) and 172.1 (C). HRMS [ESI
+
, m/z] calcd for C12H14N2O5[Na
+
] 
289.0800, found 289.0767. 
Spectroscopical data of butyl 2-acetylamino-3-(2-
nitrophenyl)propanoate (10g): Solid. Rf (50% EtOAc/hexane): 
0.34. Mp: 94-96 °C. IR (NaCl) v 3263, 3059, 1752, 1657, 1522 
and 1203 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) δ (ppm): 0.90 (t, 
3H, J= 7.4 Hz), 1.23-1.34 (m, 2H), 1.51-1.58 (m, 2H), 1.92 (s, 
3H), 3.31 (dd, 1H, J= 13.6 and 8.1 Hz), 3.49 (dd, 1H, J= 13.8 and 
6.1 Hz), 4.01-4.16 (m, 2H), 4.91 (apparent dt, 1H, J= 8.1 and 6.1 
Hz), 6.32 (br d, 1H, J= 7.6 Hz), 7.41 (m, 2H), 7.55 (dd, 1H, J= 
7.7 and 1.3 Hz) and 7.92 (d, 1H, J= 8.4 Hz). 
13
C NMR (75.5 
MHz, CDCl3) δ (ppm): 14.0 (CH3), 19.4 (CH2), 23.3 (CH3), 30.8 
(CH2), 35.2 (CH2), 53.4 (CH), 66.1 (CH2), 125.2 (CH), 128.6 
(CH), 132.0 (C), 133.1 (CH), 133.4 (CH), 149.8 (C), 170.2 (C) 
and 171.8 (C). HRMS [ESI
+
, m/z] calcd for C15H20N2O5[Na
+
] 
331.1270, found 331.1269. 
Spectroscopical data of allyl 2-acetylamino-3-(2-
nitrophenyl)propanoate (11g): Oil. Rf (50% EtOAc/hexane): 
0.71. IR (NaCl): v 3250, 1749, 1660, 1556 and 1341 cm
-1
. 
1
H 
NMR (300.13 MHz, CDCl3) δ (ppm): 1.95 (s, 3H), 3.35 (dd, 1H, 
J= 13.6 and 8.1 Hz), 3.55 (dd, 1H, J= 13.8 and 6.1 Hz), 4.55-4.68 
(m, 2H), 4.91 (apparent dt, 1H, J= 8.1 and 6.1 Hz), 5.24-5.32 (m, 
2H), 5.79-5.93 (m, 1H), 6.23 (br d, 1H, J= 7.9 Hz), 7.42 (m, 2H), 
7.55 (m, 1H) and 7.92 (dd, 1H, J= 8.4 and 1.7 Hz). 
13
C NMR 
(75.5 MHz, CDCl3) δ (ppm): 22.9 (CH3), 37.2 (CH2), 53.3 (CH), 
68.0 (CH2), 116.6 (CH2), 125.2 (CH), 128.6 (CH), 129.4 (CH), 
132.0 (C), 133.1 (CH), 133.4 (CH), 150.4 (C), 166.3 (C) and 
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170.1 (C). HRMS [ESI
+
, m/z] calcd for C14H16N2O5[Na
+
] 
315.0957, found 315.0949. 
Spectroscopical data of methyl 2-acetylamino-3-
(naphthalen-2-yl)propanoate (9h): Solid. Rf (50% 
EtOAc/hexane): 0.35. Mp= 93-95 ºC. IR (NaCl) v 3277, 3056, 
1745, 1655, 1544 and 1219 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) 
δ (ppm): 1.95 (s, 3H), 3.22 (dd, 1H, J= 20.2 and 6.3 Hz), 3.30 
(dd, 1H, J= 19.9 and 6.0 Hz), 3.71 (s, 3H), 4.97 (apparent dt, 1H, 
J=6.9 and 6.0 Hz), 6.37 (br d, 1H, J= 7.7 Hz), 7.24 (dd, 1H, J= 
8.0 and 1.6 Hz), 7.42-7.49 (m, 2H), 7.58 (s, 1H) and 7.77 (d, 3H, 
J= 3.4 Hz). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 23.3 (CH3), 
38.3 (CH2), 52.7 (CH3), 53.7 (CH), 126.2-133.9 (10 CAr), 170.4 
(C) and 172.6 (C). HRMS [ESI
+
, m/z] calcd for C16H17NO3[Na
+
] 
294.1106, found 294.1068. D
20
= -28.2 (c 1.0, CHCl3) for 27% 
ee of the (R)-enantiomer. Lit D
20
= +91.5 (c 1.0, CHCl3) for 
86% ee for the (S)-enantiomer.
15
 Lit D
20
= -104.7 (c 0.99, 
CHCl3) for >99% ee for the (R)-enantiomer.
18
 
Spectroscopical data of butyl 2-acetylamino-3-
(naphthalen-2-yl)propanoate (10h): Solid. Rf (50% 
EtOAc/hexane): 0.43. Mp: 148-150 °C. IR (NaCl) v 3280, 3056, 
1739, 1659, 1545 and 1202 cm
-1
. 
1
H NMR (300.13 MHz, CDCl3) 
δ (ppm): 0.86 (t, 3H, J= 7.2 Hz), 1.21-1.31 (m, 2H), 1.50-1.59 
(m, 2H), 1.97 (s, 3H), 3.21-3.33 (m, 2H) 4.10 (t, 2H, J= 6.6 Hz), 
4.97 (apparent dt, 1H, J= 7.1 and 6.0 Hz), 6.23 (br d, 1H, J= 7.7 
Hz), 7.26 (dd, 1H, J= 8.3 and 1.9 Hz), 7.46 (m, 2H), 7.57 (s, 1H) 
and 7.73-7.86 (m, 3H). 
13
C NMR (75.5 MHz, CDCl3) δ (ppm): 
13.6 (CH3), 19.0 (CH2), 23.1 (CH3), 30.5 (CH2), 38.2 (CH2), 53.3 
(CH), 65.4 (CH2), 125.3-133.6 (10 CAr), 169.8 (C) and 171.9 (C). 
HRMS [ESI
+
, m/z] calcd for C19H23NO3[Na
+
] 336.1576, found 
336.1544. D
20
= +90.2 (c 0.5, CHCl3) for 92% ee (S). 
Spectroscopical data of allyl 2-acetylamino-3-(naphthalen-
2-yl)propanoate (11h): Oil. Rf (50% EtOAc/hexane): 0.42. IR 
(NaCl): v 1739, 1699, 1510 and 1374 cm
-1
. 
1
H NMR (300.13 
MHz, CDCl3) δ (ppm): 1.99 (s, 3H), 3.24-3.37 (m, 2H), 4.63 (d, 
2H, J= 6.0 Hz), 5.01 (apparent dt, 1H, J= 13.0 and 5.8 Hz), 5.22-
5.34 (m, 2H), 5.80-5.93 (m, 1H), 6.09 (br d, 1H, J= 7.5 Hz), 7.26 
(dd, 1H, J= 9.0 and 1.6 Hz), 7.48 (m, 2H), 7.58 (s, 1H) and 7.74-
7.82 (m, 3H). 
13
C NMR (75 MHz, CDCl3) δ (ppm): 23.3 (CH3), 
38.2 (CH2), 53.5 (CH), 66.4 (CH2), 119.5 (CH2), 126.0-133.5 (10 
CAr), 133.6 (CH), 170.1 (C) and 171.7 (C). HRMS [ESI
+
, m/z] 
calcd for C18H19NO3[Na
+
] 320.1263, found 320.1260. D
20
= -
74.6 (c 0.5, CHCl3) for 81% ee (R). 
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